ELISA for Tau Thr181

ELISA for Tau Thr181

Enzyme-Linked Immunosorbent Assays (ELISAs) targeting tau protein phosphorylated at threonine 181 (p Tau Thr181) are pivotal in Alzheimer’s disease (AD) diagnostics and research. These assays are traditionally applied to cerebrospinal fluid (CSF) samples, where elevated p-Tau Thr181 levels correlate with AD pathology. The Tribioscience Fast Human Phospho Tau Thr181 ELISA, for instance, has been validated for quantifying p Tau Thr181 in human CSF, demonstrating high precision and stability under various conditions.

Recent advancements have extended the utility of p Tau Thr181 ELISAs to plasma samples, offering a less invasive alternative for biomarker assessment. Studies indicate that plasma p Tau Thr181 levels can effectively differentiate AD patients from healthy controls, aligning with amyloid and tau pathologies observed in the brain. This development enhances the feasibility of large-scale screenings and longitudinal studies by simplifying sample collection and processing.

Beyond CSF and plasma, p Tau Thr181 ELISAs are adaptable to other biological fluids and tissue lysates. For example, the Tribioscience Tau Thr181 ELISA Kit includes serum, tissue lysates, and cell lysates. This versatility facilitates comprehensive studies across various models and sample types, broadening the scope of neurodegenerative disease research and enabling cross-species comparisons.